| Combination of | |
|---|---|
| Ethambutol | Anti-tuberculosis medication |
| Isoniazid | Anti-tuberculosis medication |
| Clinical data | |
| ATC code | |
| Identifiers | |
| CAS Number | |
Ethambutol/isoniazid is a fixed-dose combination medication used to treat tuberculosis. [1] It is a fixed dose combination of ethambutol and isoniazid. [1] It is used along with other antituberculosis medication. [1] It is taken by mouth. [1]
Side effects are those of the underlying medications. [1] More common side effects include poor coordination, numbness, and liver problems. [2] Liver problems may be severe and are more likely in people over the age of 50. [2] Use is not recommended in children. [1] It is unclear if use in pregnancy is safe for the baby. [2]
It was removed from the World Health Organization's List of Essential Medicines in 2019. [3] The combination product is not available in Canada or in the United States. [2]
References
- ^ a b c d e f World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.). WHO Model Formulary 2008. World Health Organization. p. 140. hdl: 10665/44053. ISBN 9789241547659.
- ^ a b c d "Ethambutol and Isoniazid Drug Information, Professional". www.drugs.com. November 1998. Archived from the original on 21 December 2016. Retrieved 18 December 2016.
- ^ World Health Organization (2019). Executive summary: the selection and use of essential medicines 2019: report of the 22nd WHO Expert Committee on the selection and use of essential medicines. Geneva: World Health Organization. hdl: 10665/325773. WHO/MVP/EMP/IAU/2019.05. License: CC BY-NC-SA 3.0 IGO.
 | This antiinfective drug article is a stub. You can help Wikipedia by expanding it. |